bpc-157 fda orange book The just announced that they're taking steps to lift restrictions on 12 peptides — including and TB-500 — making them accessible through compounding pharmacies again. This is a HUGE step FDA Compliance for Peptide Therapy
Description
The 6 patients receiving TB4 experienced a 35.1% decrease in eye discomfort and a 59.1% reduction in total corneal fluorescein staining, relative to the control group [35]

Narrow and deep tracts that look like pin pricks

Because there is not enough high-quality human evidence to support routine clinical use and they are not currently approved for use in Humans by Health Canada or the FDA
Usually, the first step in cleaning the filter bed is a surface wash phase in a backwash cycle
